Nanotechnology has made a great impact on the pharmaceutical, biotechnology, food, and
cosmetics industries. More than 40% of the approved drugs are lipophilic and have poor …

Solid Lipid Nanoparticles (SLNs) have attracted increasing scientific and commercial
attention as colloidal drug carriers during the last decade. They have emerged as a potential …

Introduction: Nanoparticles are rapidly developing as drug carriers because of their size-
dependent properties. Lipid nanoparticles (LNPs) are widely employed in drug delivery …

Drug delivery technology has a wide spectrum, which is continuously being upgraded at a
stupendous speed. Different fabricated nanoparticles and drugs possessing low solubility …

Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) have opened new
horizons in the pharmaceutical industry since they play a fundamental role in the field of …

Lipid nanoparticles have attracted significant interests in the last two decades, and have
achieved tremendous clinical success since the first clinical approval of Doxil in 1995. At the …

The bioavailability of drugs is dependent on several factors such as solubility and the
administration route. A drug with poor aqueous solubility, therefore, poses challenges with …

In the past decade, research in the area of nanodrug delivery has reached a new height with
the advent of lipid based nanodrug delivery systems. Lipids being biocompatible and …

The first generation of solid lipid carrier systems in nanometer range, Solid Lipid
Nanoparticles (SLN), was introduced as an alternative to liposomes. SLN are aqueous …

The bioavailability of an orally administered drug primarily depends on its solubility in the
GIT and its permeability across cell membranes. Also, a drug in solution form is preferred for …